Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis.
Blauvelt A, Papp KA, Sofen H, Augustin M, Yosipovitch G, Katoh N, Mrowietz U, Ohtsuki M, Poulin Y, Shrom D, Burge R, See K, Mallbris L, Gordon KB. Blauvelt A, et al. Among authors: ohtsuki m. J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1004-1013. doi: 10.1111/jdv.14163. Epub 2017 Mar 31. J Eur Acad Dermatol Venereol. 2017. PMID: 28190255 Free PMC article. Clinical Trial.
Long-term continuous versus intermittent cyclosporin: therapy for psoriasis.
Ohtsuki M, Nakagawa H, Sugai J, Ozawa A, Ohkido M, Nakayama J, Hanada J, Morimoto Y, Jimbow K, Horikoshi T, Kitahara H, Tamaki K, Urabe K, Hori Y. Ohtsuki M, et al. J Dermatol. 2003 Apr;30(4):290-8. doi: 10.1111/j.1346-8138.2003.tb00390.x. J Dermatol. 2003. PMID: 12707465 Clinical Trial.
Japanese guidance for use of biologics for psoriasis (the 2013 version).
Ohtsuki M, Terui T, Ozawa A, Morita A, Sano S, Takahashi H, Komine M, Etoh T, Igarashi A, Torii H, Asahina A, Nemoto O, Nakagawa H; Biologics Review Committee of the Japanese Dermatological Association. Ohtsuki M, et al. J Dermatol. 2013 Sep;40(9):683-95. doi: 10.1111/1346-8138.12239. J Dermatol. 2013. PMID: 24033880
Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study.
Asahina A, Etoh T, Igarashi A, Imafuku S, Saeki H, Shibasaki Y, Tomochika Y, Toyoizumi S, Nagaoka M, Ohtsuki M; study investigators. Asahina A, et al. Among authors: ohtsuki m. J Dermatol. 2016 Aug;43(8):869-80. doi: 10.1111/1346-8138.13258. Epub 2016 Feb 15. J Dermatol. 2016. PMID: 26875540 Free PMC article. Clinical Trial.
406 results